What You Should Know
- Moffitt Cancer Center has announced the expansion of its hybrid virtual oncology care program with Reimagine Care, deploying the conversational AI-powered assistant Remi alongside a dedicated virtual clinical team.
- An initial implementation phase covering nearly 7,000 digital patient interactions demonstrated that 97% of patient encounters were independently resolved virtually without requiring escalation to Moffitt providers.
- Continuous home monitoring and automated symptom pathway tracking successfully kept cancer patients out of the hospital, with only 2.4% of digital interactions resulting in emergency department referrals.
- The model achieved a six-month patient program retention rate of 63%—more than triple the traditional digital health industry baseline of less than 20% engagement beyond 90 days.
- Backed by an average patient satisfaction score of 9.3 out of 10, the scaled rollout will expand AI-supported workflows across additional physical Moffitt locations to mitigate ongoing oncologist capacity constraints.
The delivery of modern oncology care is increasingly constrained by an acute combination of rising patient volumes, severe clinician burnout, and the compounding complexity of advanced therapeutic regimens. Historically, cancer treatment has operated on a transactional model defined by periodic snapshots captured during scheduled, in-person clinic visits. Yet, the grueling realities of oncological side effects—such as treatment-induced toxicities, sudden symptom flares, and profound psychological distress—unfold constantly in the gaps between those appointments.
When these symptoms are left unmanaged at home, they become the primary drivers of preventable emergency department visits and costly hospitalizations, placing a severe financial and operational strain on both patients and healthcare infrastructure. For major health systems looking to expand capacity without proportionally increasing expensive clinical staffing demands, transitioning to proactive, continuous hybrid care models has become an operational necessity.
To address this challenge and hardwire 24/7 oncology oversight directly into the home, Moffitt Cancer Center has announced the expansion of its strategic partnership with Reimagine Care. Following a highly successful initial deployment phase, the expanded rollout will scale Reimagine Care’s conversational AI assistant, Remi, alongside a dedicated virtual oncology team to establish a continuous clinical signal across additional Moffitt locations.
Unprecedented Trial Validation: 97% Independent Resolution
While the digital health ecosystem is frequently flooded with early-stage generative AI pilots that struggle to prove structural efficacy, the collaboration between Moffitt and Reimagine Care enters its next phase backed by clear, real-world data.
An evaluation of nearly 7,000 distinct patient interactions—encompassing proactive check-ins, electronic patient-reported outcomes (ePROs), automated symptom pathways, and clinical escalations—revealed exceptional operational and financial returns:
- Virtually Managed Care: A staggering 97% of all patient encounters were independently resolved by Reimagine Care’s integrated platform, completely bypassing the need to escalate care or add administrative burdens to primary Moffitt providers.
- Deflecting Inpatient Crises: Proactive, early-stage intervention resulted in only 2.4% of total patient interactions requiring emergency department referrals.
- Sustained Home Recovery: 94% of acute symptom management encounters were resolved entirely virtually, allowing patients to recover safely inside their own homes.
Dan Nardi, CEO of Reimagine Care, emphasized that the only way to sustain this level of rigorous longitudinal visibility is by combining frontline clinical teams with an “always-on” AI engine. By capturing subtle physiological changes, guiding patients through evidence-based care pathways, and surfacing real-time insights, the software allows health systems to expand high-quality oncology care far beyond the physical clinic walls.
Overcoming the 90-Day Digital Health Engagement Cliff
A persistent failure mode defining traditional consumer-facing digital health products is rapid user abandonment, with typical industry retention rates plunging below 20% after the first 90 days. Reimagine Care has systematically dismantled this trend, documenting an exceptional 99% patient engagement rate in month one, which sustained at 81% in month two, 76% in month three, and maintained a massive 63% program retention rate at the six-month mark.
This sustained patient trust is heavily driven by the high-touch, natural conversational design of the platform. Backed by an average satisfaction score of 9.3 out of 10, patients frequently cited the empathetic quality of Remi’s automated wellness check-ins and the rapid responsiveness of the virtual clinical network. Tim Hembree, DO, PhD, Vice President and Chief Quality Officer at Moffitt Cancer Center, noted that this continuous validation loop gives care teams total visibility into complex patient populations, enabling them to intervene earlier and provide a more consistent safety net throughout the treatment lifecycle.
